Skip to main content

Table 2 Perioperative course and postoperative outcome

From: Outcomes of hemi- versus whole liver transplantation in patients from mainland china with high model for end-stage liver disease scores: a matched analysis

Variables

MELD < 30

MELD ≥ 30

WG (n = 323)

HG (n = 323)

P

WG (n = 88)

HG (n = 35)

P

Warm ischemia time (mins)

8.50 ± 3.82

13.02 ± 4.00

 < 0.01

8.14 ± 3.29

14.57 ± 3.16

 < 0.01

Cold ischemia time (hours)

3.37 ± 2.2

3.17 ± 1.21

0.137

3.39 ± 1.27

3.24 ± 3.44

0.801

Operation time (h)

8.22 ± 2.67

9.55 ± 2.01

 < 0.01

8.12 ± 2.03

10.06 ± 3.2

0.002

ICU stays (days)

4.69 ± 2.51

5.24 ± 1.24

 < 0.01

4.76 ± 1.55

5.17 ± 1.58

0.191

Postoperative hospital stays (days)

11.06 ± 3.78

12.38 ± 6.59

 < 0.01

11.56 ± 4

15.51 ± 5.89

0.001

Intraoperative blood loss (mL)

746.16 ± 441.64

856.97 ± 351.36

 < 0.01

864.77 ± 319.14

1240 ± 795.37

0.010

Blood transfusion (mL)

384.52 ± 238.28

442.11 ± 198.34

0.001

437.5 ± 205.84

717.14 ± 584.35

0.009

EAD (%)

4 (1.2%)

3 (0.9%)

NS

1 (1.1%)

1 (2.9%)

NS

PNF (%)

1 (0.3%)

0 (0.3%)

NS

0

0

NS

Postoperative infection (%)a

18 (5.6%)

17 (5.3%)

0.862

12 (13.6%)

6 (17.1%)

0.620

Vascular complication (%)b

6 (1.9%)

20 (6.2%)

0.005

3 (3.4%)

2 (5.7%)

0.938

Biliary complications (%)c

8 (2.5%)

14 (4.3%)

0.193

3 (3.4%)

3 (8.6%)

0.462

Intra-abdominal bleeding (%)

11 (3.4%)

22 (6.8%)

0.049

6 (6.8%)

4 (11.4%)

0.632

Clavien–Dindo ≥ Grade 3 (%)

40 (12.4%)

52 (16.1%)

0.177

10 (11.4%)

9 (25.7%)

0.047

  1. EAD early allograft dysfunction, PNF primary nonfunction
  2. aPostoperative infection including lung infection, urinary tract infection, abdominal abscess, wound infection, peritonitis, and positive blood culture
  3. bVascular complication including embolization and/or stenosis of any of the hepatic arteries, portal veins, and inferior vena cava
  4. cBiliary complications including biliary stricture, biliary bleeding, or bile leakage